Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker tips: ARM, Tate & Lyle, Inchcape

Fri, 01st Apr 2016 15:46

(ShareCast News) - Numis sell-side analysts provided a list of their top picks among large and small cap stocks across the market, including ARM Holdings, Virgin Money, Derwent London, Tullow Oil, Northgate and Vectura.After another strong set of quarterly results, ARM remains the top pick as Numis believes the recent investments should be taken as a sign of confidence that historic growth rates can be sustained as ARM deepens its value add in existing markets and continues to address new markets."The analyst meeting indicated confidence in further growth in mobile despite slower growth in smartphone volumes, with growth coming from higher royalties with increased performance as with v8, multiple cores and additional IP," the broker said, with strong prospects in enterprise infrastructure and 'embedded intelligence'.The stock trades at a p/e of 28.8x, below the bottom of the 30-55x historic range, whereas prospects to sustain earnings growth at least in the high teens "continue to remain very strong".Virgin Money was added to the list on the view that it will continue to benefit from both strong earnings growth and improving return on tangible equity (ROTE) while markets remain favourable and mainstream competition is "distracted/restricted"."Furthermore, improved utilisation of the operating infrastructure acquired from Northern Rock should, in our view, underpin significant balance sheet growth for very little incremental cost." A target price of 490p is more than £1 above the current market price.Derwent London is another new addition to the top picks portfolio, replacing British Land, with the comment that its return profile evolved through FY15 with the mix of returns has shifting from yields to estimated rental value (ERV) growth.ERVs have been accelerating since early 2013, they remain some way below levels seen in 2006 but, while slowing, are thought likely to remain positive through to 2019."Rising construction capacity constraints and cost inflation increase the likelihood of delays across the broader London development pipeline but DLN has locked in construction packages and costs, in pound-terms, on three of its four live developments, and is close to finalising the remaining package for 80 Charlotte St."While there are macro uncertainties such as the mayoral election and Brexit vote, a strong balance sheet, an attractive development pipeline and significant organic reversion off low passing rents, gives analysts confidence in their 3,850p target price.Tullow, despite being among the most shorted stocks on the FTSE, remains in the list on analysts belief that Tullow "could be ideally positioned for a future recovery in oil prices", as it is able to withstand a period of low oil prices while completing its major development project, the TEN field offshore Ghana where first oil is due in the middle of this year.On Vectura, Numis set a price target of 264p, offering around 60% updside to the current price on a 12-month view as the respiratory specialist merges with peer Skyepharma in "one of the most complementary mergers in the UK Healthcare sector", as the enlarged group has competitive advantages in both drug delivery and respiratory formulations and offers exposure to several emerging royalty streams through partnerships with Big Pharma partners."Vectura specifically benefits from Skyepharma's fast growing earnings and cash-flow, which will, in our opinion, accelerate the enlarged group's transition to being a specialist pharmaceutical company with the financial strength to commercialise novel drugs and devices in niche segments itself."House stock Northgate is another new name on the list, with a target price of 560p as the shares are felt to offer an "attractive combination of cyclical and selfhelp growth drivers, income attractions, and a valuation that reflects the historicchanges to the depreciation rates and UK operational issues, rather than the scope for further improvement". Tate & Lyle was under the cosh on Friday after Canaccord Genuity cut its earnings forecasts ahead of the company's full year trading update.Canaccord said recovery in Mexican and Brazilian currencies, reduced interest costs and an increased contribution from joint ventures has been offset by higher than anticipated central costs.Central costs were driven by a rise in depreciation and amortisation costs, particularly in Tate's Specialty Foods Ingredients (SFI) business.Canaccord now expects earnings per share of 33.8p in 2016, compared to a previous estimate of 34.7p and the prior year's 37.7p. However, the broker said new estimates have been brought in line with current consensus expectations."Ultimately, however, we think Tate's share price will be driven by further evidence of stability in sucralose following the transition to a single production plant, improving profitability in HFCS (high fructose corn syrup) and greater focus on SFI, while essentially running Bulk for cash," said analyst Eddy Hargreaves."We remain positive on management's ability to deliver this and note the recent better-than-expected performance from sucralose following the restructuring actions."Canaccord reiterated its 'buy' rating and target price of 685p, saying the shares have recovered modestly since the third quarter update on 11 February and "remain attractive in our view". Berenberg has downgraded Inchcape to 'hold' from 'buy' on new-found concerns for the car dealer's businesses in the UK, Hong Kong and Australia.Although the stock is cheap on a p/e ratio basis, Berenberg said, the three business account for almost two-thirds of group operating profit and could put earnings per share momentum at risk over the next year.The concerns in the UK relate to Inchcape's margins declining to their lowest level since 2008 in contrast with the rest of the market, largely felt due to the company's large exposure to Volkswagen in the UK, representing around 20% of retail franchises and where sales have come under pressure last year following the emissions-cheating scandal.While Inchcape's management declined to provide exact figures on the UK impact of the scandal, Berenberg believes in the fourth quarter alone it could have amounted to a loss of circa £3m to EBIT - or 5% of full year UK profit."With VW sales in the UK down by 13.5% year to date, we believe Inchcape's UK business could be at risk if this trend continues," the German bank said in its note, with the UK being 20% of 2016 expected EBIT.As for Australia, which represents 26% of 2016 EBIT, the concerns relate to the big focus on Subaru, which is bought in Japanese yen and so the deprecation of the Australian dollar presents a risk to margins."While the company believes that it can share some of this pain with the dealer network, we wait to see how much can be passed on," Berenberg said, rubbing out £3m of its EBIT forecast for the unit and warning it could arguably be more.Although the Hong Kong dollar's appreciation is expected to generate a £6m tailwind, analysts fear Inchcape's business in north Asia will not grow at all in EBIT terms in 2016, given the major slowdown in consumer and business confidence there.Berenberg has cut its price target to 735p, from 915p, on EPS forecasts cut to 54.3p from 55.64p for 2016.
More News
2 Aug 2021 15:41

LIVE MARKETS-Wall Street kicks off August on the plus side

* U.S. equity indexes higher, Dow out front, chips strong* Financials lead S&P sector gainers; staples weakest group* Euro STOXX 600 index up ~0.5%* Gold flat; dollar, crude, bitcoin all dip* U.S. 10-Year Treasury yield ~1.19%Aug 2 - Welcome to the h...

Read more
2 Aug 2021 14:24

LIVE MARKETS-When M&A is Made in Britain

* U.S. equity index futures suggest modest opening gains* Euro STOXX 600 index up ~0.5%* Dollar, gold, crude, bitcoin all dip* U.S. 10-Year Treasury yield ~1.21%Aug 2 - Welcome to the home for real-time coverage of markets brought to you by Reuters ...

Read more
26 Jul 2021 12:33

Philip Morris to end Marlboro cigarette sales in UK within a decade

July 26 (Reuters) - Tobacco group Philip Morris International will stop selling Marlboro cigarettes in Britain within a decade, its chief executive told https://www.dailymail.co.uk/news/article-9822189/Tobacco-giant-Philip-Morris-stop-selling-cigar...

Read more
18 Jul 2021 11:35

Sunday newspaper roundup: Vectura, Sunak, Cobham

(Sharecast News) - "The head of Marlboro cigarette-maker Philip Morris International (PMI) has hit out at critics of a controversial swoop on a healthcare company, claiming that the acquisition will help achieve its target to make the UK smoke-free within a decade. In the wake of fierce opposition to the deal to buy FTSE 250 inhaler-maker Vectura, André Calantzopoulos, PMI's executive chairman, said the "obsessive focus" by anti-smoking campaigners on Big Tobacco was the "wrong approach", adding that PMI has the "ability and the technology" to address harm from smoking." - Sunday Telegraph

Read more
12 Jul 2021 10:06

BROKER RATINGS: Morgan Stanley cuts Wizz Air but upgrades easyJet

BROKER RATINGS: Morgan Stanley cuts Wizz Air but upgrades easyJet

Read more
9 Jul 2021 17:25

LONDON MARKET CLOSE: Investors shake off woes, back on "rally train"

LONDON MARKET CLOSE: Investors shake off woes, back on "rally train"

Read more
9 Jul 2021 12:07

LONDON MARKET MIDDAY: Stocks shake off global recovery worries

LONDON MARKET MIDDAY: Stocks shake off global recovery worries

Read more
9 Jul 2021 10:59

TOP NEWS SUMMARY: Philip Morris snatches Vectura from Carlyle Group

TOP NEWS SUMMARY: Philip Morris snatches Vectura from Carlyle Group

Read more
9 Jul 2021 09:59

LIVE MARKETS-UK for sale

Welcome to the home for real-time coverage of markets brought to you by Reuters stocks reporters.UK FOR SALE (0859 GMT)There's been a burst of M&A activity in the UK in recent weeks, with Spire Healthcare , Morrison Supermarkets and Vectura all bei...

Read more
9 Jul 2021 08:42

LONDON MARKET OPEN: Stocks recover into end of week as airlines rise

LONDON MARKET OPEN: Stocks recover into end of week as airlines rise

Read more
9 Jul 2021 08:10

LONDON BRIEFING: Marlboro Man seeks asthma treatment

LONDON BRIEFING: Marlboro Man seeks asthma treatment

Read more
9 Jul 2021 07:46

LONDON MARKET PRE-OPEN: Philip Morris strikes GBP1 billion Vectura buy

LONDON MARKET PRE-OPEN: Philip Morris strikes GBP1 billion Vectura buy

Read more
9 Jul 2021 07:40

TOP NEWS: Vectura backs GBP1 billion takeover by Philip Morris Intl

TOP NEWS: Vectura backs GBP1 billion takeover by Philip Morris Intl

Read more
9 Jul 2021 07:31

UPDATE 4-Cigarette maker Philip Morris to buy UK producer of respiratory treatments

* Vectura withdraws support for Carlyle deal* UK firm recommends Philip Morris offer* Deal is second by Philip Morris in a week* Shares jump 14% (Adds industry context, analyst comments, updates shares)By Yadarisa Shabong and Siddharth CavaleJuly 9 ...

Read more
9 Jul 2021 07:31

UPDATE 3-Cigarette maker Philip Morris to buy UK producer of respiratory treatments

* Vectura withdraws support for Carlyle deal* UK firm recommends Philip Morris offer* Deal is second by Philip Morris in a week* Shares jump 14% (Adds Carlyle statement, analyst comment, detail, updates shares)By Yadarisa ShabongJuly 9 (Reuters) - ...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.